Finance

Lists
DVLA:IDX
Darya-Varia Laboratoria Tbk PT
IDR 1,585.00
0.00%
(0.00) 1D
Oct 7, 4:00:04 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for DVLA...
Open
IDR 1,580
High
IDR 1,585
Low
IDR 1,580
Mkt. cap
1.78T
Avg. vol.
49.06K
Volume
12.40K
Dividend
6.62%
Quarterly dividend
IDR 26
Ex-dividend date
Jun 30, 2026
P/E ratio
13.04
52-wk high
IDR 1,715
52-wk low
IDR 1,450
EPS
IDR 122
Shares outstanding
1.12B
No. of employees
1K
Open
IDR 1,580
High
IDR 1,585
Low
IDR 1,580
Mkt. cap
1.78T
Avg. vol.
49.06K
Volume
12.40K
Dividend
6.62%
Quarterly dividend
IDR 26
Ex-dividend date
Jun 30, 2026
P/E ratio
13.04
52-wk high
IDR 1,715
52-wk low
IDR 1,450
EPS
IDR 122
Shares outstanding
1.12B
No. of employees
1K
News stories
From web sources and news partners
About Darya-Varia Laboratoria Tbk PT
CEO-
Employees1.36K
Founded1976
Headquarters-
SectorPharmaceutical industry
Websitedarya-varia.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
542.09B
603.56B
594.80B
613.80B
Cost of goods sold
248.96B
282.05B
293.42B
307.37B
Cost of revenue
248.96B
282.05B
293.42B
307.37B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
240.88B
325.49B
232.36B
260.41B
Operating expense
240.85B
321.90B
229.76B
256.37B
Total operating expenses
489.81B
603.94B
523.18B
563.74B
Operating income
52.28B
-389.20M
71.62B
50.06B
Other non operating income
-
-
-
-
EBT including unusual items
55.36B
1.20B
72.98B
52.74B
EBT excluding unusual items
54.88B
742.83M
72.98B
51.36B
Income tax expense
12.47B
1.59B
17.67B
14.33B
Effective tax rate
22.52%
131.98%
24.21%
27.17%
Other operating expenses
-26.40M
-3.59B
-2.60B
-4.04B
Net income
42.89B
-384.24M
55.31B
38.41B
Net profit margin
7.91%
-0.06%
9.30%
6.26%
Earnings per share
-
-
-
-
Interest and investment income
1.08B
1.05B
662.79M
1.22B
Interest expense
-7.88M
-5.36M
-1.93M
-1.49M
Net interest expenses
1.07B
1.04B
660.86M
1.21B
Depreciation and amortization charges
-
-
-
-
EBITDA
69.92B
18.80B
92.79B
67.72B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps